E2F-1 blocks terminal differentiation and causes proliferation in transgenic megakaryocytes

Molecular and Cellular Biology

Volumn 16, Issue 2, 1996, Pages 685-693

  Guy, Chantale T ^a   Zhou, Wen ^a   Kaufman, Stephen ^a   Robinson, Murray O ^a  

^a AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR; PLATELET DERIVED GROWTH FACTOR; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; MEGAKARYOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTOPENIA; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 0030031542     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.16.2.685     Document Type: Article

References (58)

1. An, E., K. Ogata, S. Kuriya, and T. Nomura. 1994. Interleukin-6 and erythropoietin act as direct potentiators and inducers of in vitro cytoplasmic process formation on purified mouse megakaryocytes. Exp. Hematol. 22: 149-136.
2. Bandara, L. R., V. M. Buck, M. Zamanian, L. H. Johnston, and N. B. La Thangue. 1993 Functional synergy between DP-1 and E2F-1 in the cell cycle-regulating transcription factor DRTF1/E2F. EMBO J. 12:4317-4324
3. Bartley, T. D., J. Bogenberger, P. Hunt, Y. S. Li, H. S. Lu, F. Martin, M. S. Chang, B. Samal, J. L. Nichol, S. Swift, et al. 1994. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl Cell 77:1117-1124.
4. Beijersbergen, R. L., R. M. Kerkhoven, L. Zhu, L. Carlee, P. M. Voorhoeve, and R. Bernards. 1994. E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo. Genes Dev 8:2680-2690.
5. Clarke, A. R., E. R. Maandag, M. van Roon, N. M. T. van der Lugt, M. van der Valk, M. L. Hooper, A. Berns, and H. te Riele. 1992 Requirement for a functional Rb-1 gene in murine development. Nature (London) 359:328-330
6. Dimri, G. P., E. Hara, and J. Campisi. 1994. Regulation of two E2F-related genes in presenescent and senescent human fibroblasts. J. Biol. Chem. 269: 16180-16186
7. Dou, Q. P., S. Zhao, A. H. Levin, J. Wang, K. Helin, and A. B. Pardee. 1994 G1/S-regulated E2F-containing protein complexes bind to the mouse thymidine kinase gene promoter. J Biol. Chem. 269:1306-1313.
8. Fisher, D. E. 1994. Apoptosis in cancer therapy: crossing the threshold. Cell 78:539-542.
9. Flemington, E. K., S. H. Speck, and W. G. Kaelin, Jr. 1993. E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product Proc. Natl Acad Sci. USA 90:6914-6918
10. Gewirtz, A. M., and M. Poncz. 1991 Megakaryocytopoiesis and platelet production, p. 1148-1157. In R. Hoffman, E. J Benz, S. J. Shattil, B Furie, and H J. Cohen (ed.), Hematology: basic principles and practice. Churchill Livingstone, New York.
11. Ginsberg, D., G. Vairo, T. Chittenden, Z. X. Xiao, G. Xu, K. L. Wydner, J. A. DeCaprio, J. B. Lawrence, and D. M. Livingston, 1994. E2F-4, a new member of the E2F transcription factor family, interacts with p107. Genes Dev 8: 2665-2679
12. Girling, R., J. F. Partridge, L. R. Bandara, N. Burden, N. F. Totty, J. J. Hsuan, and N. B. La Thangue. 1993 A new component of the transcription factor DRTF1/E2F. Nature (London) 362:83-87.
13. Gu, W., J. W. Schneider, G. Condorelli, S. Kaushal, V. Mahdavi, and B. Nadal Ginard. 1993. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72:309-324.
14. Halevy, O., B. G. Novitch, D. B. Spicer, S. X. Skapek, J. Rhee, G. J. Hannon, D. Beach, and A. B. Lassar. 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267:1018-1021
15. Helin, K., E. Harlow, and A. Fattaey. 1993. Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol. Cell. Biol 13: 6501-6508.
16. Helin, K., J. A. Lees, M. Vidal, N. Dyson, E. Harlow, and A. Fattaey. 1992 A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell 70:337-350.
17. Helin, K., C. L. Wu, A. R. Fattaey, J. A. Lees, B. D. Dynlacht, C. Ngwu, and E. Harlow. 1993. Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation. Genes Dev. 7:1850-1861.
18. Hoffman, R. 1989. Regulation of megakaryocytopoiesis Blood 74:1196-1212.
19. Hogan, B., F. Costantini, and E. Lacy, 1986. Manipulating the mouse embryo: a laboratory manual, p. 152-182. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
20. Hsiao, K. M., S. L. McMahon, and P. J. Farnham. 1994. Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter. Genes Dev. 8:1526-1537.
21. Ishibashi, T., H. Kimura, Y. Shikama, T. Uchida, S. Kariyone, T. Hirano, T. Kishimoto, F. Takatsuki, and Y. Akiyama. 1989. Interleukin-6 is a potent thrombopoietic factor in vivo in mice. Blood 74:1241-1244.
22. Ivey, H.-M., R. Conroy, H. E. Huber, P. J. Goodhart, A. Oliff, and D. C. Heimbrook. 1993. Cloning and characterization of E2F-2, a novel protein with the biochemical properties of transcription factor E2F. Mol. Cell. Biol. 13:7802-7812.
23. Jacks, T., A. Fazeli, E. M. Schmitt, R. T. Bronson, M. A. Goodell, and R. A. Weinberg. 1992. Effects of an Rb mutation in the mouse. Nature (London) 359:295-300
24. Johnson, D. G., W. D. Cress, L. Jakoi, and J. R. Nevins. 1994. Oncogenic capacity of the E2F1 gene. Proc. Natl. Acad. Sci. USA 91:12823-12827.
25. Johnson, D. G., K. Ohtani, and J. R. Nevins. 1994. Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression. Genes Dev. 8:1514-1525.
26. Johnson, D. G., J. K. Schwarz, W. D. Cress, and J. R. Nevins. 1993 Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature (London) 365:349-352
27. Kaelin, W. G., Jr., W. Krek, W. R. Sellers, J. A. DeCaprio, F. Ajchenbaum, C. S. Fuchs, T. Chittenden, Y. Li, P. J. Farnham, M. A. Blanar, et al. 1992. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell 70:351-364.
28. Krek, W., D. M. Livingston, and S. Shirodkar. 1993. Binding to DNA and the retinoblastoma gene product promoted by complex formation of different E2F family members. Science 262:1557-1560.
29. Lam, E. W., and R. J. Watson. 1993. An E2F-binding site mediates cell-cycle regulated repression of mouse B-myb transcription. EMBO J. 12:2705-2713.
30. La Thangue, N. B. 1994. DRTF1/E2F: an expanding family of heterodimeric transcription factors implicated in cell-cycle control. Trends Biochem. Sci. 19:108-114.
31. Lee, E. Y., C. Y. Chang, N. Hu, Y. C. Wang, C. C. Lai, K. Herrup, W. H. Lee, and A. Bradley. 1992. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature (London) 359:288-294.
32. Lees, J. A., M. Saito, M. Vidal, M. Valentine, T. Look, E. Harlow, N. Dyson, and K. Helin. 1993. The retinoblastoma protein binds to a family of E2F transcription factors. Mol. Cell. Biol 13:7813-7825.
33. Lok, S., K. Kaushansky, R. D. Holly, J. L. Kuijper, C. E. Lofton-Day, P. J. Oort, F. J. Grant, M. D. Helpel, S. K. Burkhead, J. M. Kramer, L. A. Bell, and C. A. Spreeher. 1994. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature (London) 369: 565-568.
34. Mudrak, I., E. Ogris, H. Rotheneder, and E. Wintersberger. 1994. Coordinated trans activation of DNA synthesis- and precursor-producing enzymes by polyomavirus large T antigen through interaction with the retinoblastoma protein. Mol. Cell. Biol. 14:1886-1892.
35. Mudryj, M., S. W. Hiebert, and J. R. Nevins. 1990. A role for the adenovirus inducible E2F transcription factor in a proliferation dependent signal transduction pathway. EMBO J. 9:2179-2184.
36. Neuman, E., E. K. Flemington, W. R. Sellers, and W. G. Kaelin, Jr. 1994. Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter. Mol. Cell. Biol. 14:6607-6615.
37. Nevins, J. R. 1992 E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258:424-429.
38. Novak, E. K., M. Reddington, L. Zhen, P. E. Sternberg, C. W. Jackson, M. P. McGarry, and R. T. Swank. 1995 Inherited thrombocytopenia caused by reduced platelet production in mice with the gunmetal pigment gene mutation. Blood 85:1781-1789.
39. Odell, T. T., and C. W. Jackson. 1968. Polyploidy and maturation of megakaryocytes. Blood 32:102-110.
40. Parker, S. B., G. Eichele, P. Zhang, A. Rawls, A. T. Sands, A. Bradley, E. N. Olson, J. W. Harper, and S. J. Elledge. 1995. p53-independent expression of p21/cip1 in muscle and other terminally differentiating cells. Science 267: 1024-1027.
41. Qin, X. Q., D. M. Livingston, W. G. Kaelin, Jr., and P. D. Adams. 1994. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA 91:10918-10922.
42. Ravid, K., D. L. Beeler, M. S. Rabin, H. E. Ruley, and R. D. Rosenberg. 1991. Selective targeting of gene products with the megakaryocyte platelet factor 4 promoter. Proc. Natl. Acad. Sci. USA 88:1521-1525.
43. Robinson, M. O., and M. I. Simon. 1991. Determining transcript number using the polymerase chain reaction: Pgk-2, mP2, and PGK-2 transgene mRNA levels during spermatogenesis. Nucleic Acids Res. 19:1557-1562.
44. Robinson, M. O., W. Zhou, M. Hokum, D. M. Danilenko, R.-Y. Hsu, R. E. Atherton, W. Xu, S. Mu, C. Saris, S. Swift, G. Elliot, J. Del Castillo, P. Hunt, and R. A. Bosselman. 1994. The tsA58 simian virus 40 large tumor antigen disrupts megakaryocyte differentiation in transgenic mice Proc. Natl. Acad. Sci. USA 91:12798-12802.
45. Sala, A., N. C. Nicolaides, A. Engelhard, T. Bellon, D. C. Lawe, A. Arnold, X. Grana, A. Giordano, and B. Calabretta. 1994. Correlation between E2F-1 requirement in the S phase and E2F-1 transactivation of cell cycle-related genes in human cells. Cancer Res. 54:1402-1406.
46. Schulze, A., K. Zerfass, D. Spitkovsky, B. Henglein, and D.-P. Jansen. 1994. Activation of the E2F transcription factor by cyclin D1 is blocked by p16INK4, the product of the putative tumor suppressor gene MTS1. Oncogens 9:3475-3482
47. Schwarz, J. K., C. H. Bassing, I. Kovesdi, M. B. Datto, M. Blazing, S. George, X. F. Wang, and J. R. Nevins. 1995. Expression of the E2F1 transcription factor overcomes type beta transforming growth factor-mediated growth suppression. Proc. Natl. Acad. Sci. USA 92:483-487.
48. Shan, B., and W. H. Lee. 1994. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis Mol. Cell. Biol. 14:8166-8173.
49. Shan, B., X. Zhu, P. L. Chen, T. Durfee, Y. Yang, D. Sharp, and W. H. Lee. 1992. Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F. Mol. Cell. Biol. 12:5620-5631.
50. Shivdasani, R. A., M. F. Rosenblatt, D. Zucker-Franklin, C. W. Jackson, P. Hunt, C. J. M. Saris, and S. H. Orkin. 1995. Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell 81:695-704.
51. Singh, P., S. H. Wong, and W. Hong. 1994. Overexpression of E2F-1 in rat embryo fibroblasts leads to neoplastic transformation EMBO J. 13:3329-3338.
52. Skapek, S. X., J. Rhee, D. B. Spicer, and A. B. Lassar. 1995. Inhibition of myogenic differentiation m proliferating myoblasts by cyelin D1-dependent kinase. Science 267:1022-1024.
53. Slansky, J. E., Y. Li, W. G. Kaelin, and P. J. Farnham. 1993. A protein synthesis-dependent increase m E2F1 mRNA correlates with growth regulation of the dihydrofolate reductase promoter. Mol. Cell. Biol 13:1610-1618.
54. Surh, C. D., and J. Sprent. 1994. T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature (London) 372:100-103.
55. Szekely, L., W. Q. Jiang, F. Bulic Jakus, A. Rosen, N. Ringertz, G. Klein, and K. G. Wiman. 1992. Cell type and differentiation dependent heterogeneity in retinoblastoma protein expression in SCID mouse fetuses. Cell Growth Differ 3:149-156.
56. Wiman, K. G. 1993. The retinoblastoma gene: role in cell cycle control and cell differentiation. FASEB J. 7:841-845.
57. Wu, X., and A. J. Levine. 1994. E2F-1 and p53 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA 91:3602-3606.
58. Xu, G., D. M. Livingston, and W. Krek. 1995. Multiple members of the E2F transcription factor family are the products of oncogenes. Proc Natl. Acad. Sci. USA 92:1357-1361.